This review article explores the glutathione (GSH) system as a promising therapeutic target in neurological and neuropsychiatric disorders, highlighting its vital role in maintaining redox balance, reducing oxidative stress, and modulating neuroinflammation. Disruptions in GSH metabolism are linked to conditions such as schizophrenia, bipolar disorder, autism, Alzheimer’s, Parkinson’s, and major
